Soligenix Inc
Change company Symbol lookup
Select an option...
SNGX Soligenix Inc
IDCC InterDigital Inc
HON Honeywell International Inc
AXP American Express Co
PNGAY Ping An Insurance Group Co of China Ltd
YRIV Yangtze River Port and Logistics Ltd
PINVF Pinnacle Investment Management Group Ltd
PNFPP Pinnacle Financial Partners Inc
KGHZF Pangolin Diamonds Corp
PUCCF Pancontinental Resources Corporation
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Soligenix, Inc. (Soligenix) is a late-stage biopharmaceutical company. The Company is focused on developing and commercializing products to treat rare diseases. The Company operates through two business segments: Specialized BioTherapeutics and Public Health Solution. Soligenix’s Specialized BioTherapeutics business segment is developing a photodynamic therapy (SGX301) utilizing topical synthetic hypericin activated with safe visible fluorescent light for the treatment of cutaneous T-cell lymphoma (CTCL). The Public Health Solutions business segment includes active development programs for RiVax, its ricin toxin vaccine candidate and SGX943, its therapeutic candidate for antibiotic-resistant and emerging infectious disease. CTCL is its innate defense regulator technology, dusquetide (SGX942) for the treatment of oral mucositis in head and neck cancer.

Closing Price
$0.9646
Day's Change
-0.0194 (-1.97%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.988
Day's Low
0.9425
Volume
(Below Average)
Volume:
257,052

10-day average volume:
306,318
257,052
  • Prev Close
    0.984
  • Today's Open
    0.985
  • Day's Range
    0.9425-0.988
  • Avg Vol (10-day)
    306.3K
  • Last (time)
    3:59p ET 07/23/21
  • Last (size)
    9
  • 52-Wk Range
    0.855 - 2.99
    LowHigh
  • (07/28/20 - 05/13/21)
    12.82%
  • 105.5%
  • Market Cap
    38.7M
  • Shares Outstanding
    40.1M
  • -0.41
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.3
  • 9.88
  • (% of float 06/30/21)
    2.45

Latest News

July 22, 2021
8:35 am ET
Newsfile
July 08, 2021
11:21 am ET
Accesswire
July 06, 2021
3:39 pm ET
Globe Newswire
8:35 am ET
Newsfile
June 23, 2021
9:35 am ET
Accesswire
June 22, 2021
7:30 am ET
PR Newswire
June 17, 2021
7:48 am ET
Globe Newswire
June 10, 2021
7:30 am ET
PR Newswire
June 09, 2021
7:30 am ET
PR Newswire
May 20, 2021
7:30 am ET
PR Newswire
May 17, 2021
7:30 am ET
PR Newswire
May 10, 2021
7:30 am ET
PR Newswire
May 04, 2021
7:30 am ET
PR Newswire
April 28, 2021
7:30 am ET
PR Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.